
Dr. Yadagiri R. Pendri Reappointed As Independent Director Of Vimta Labs
Dr Yadagiri R. Pendri has been reappointed as an Independent Director of Vimta Labs Limited, commencing from August 10, 2025.
Dr Pendri has over 35 years of experience in pharmaceutical research and development. He is the Founder and CEO of Escientia Lifesciences, a contract development and manufacturing organisation supplying active pharmaceutical ingredients to global pharmaceutical and biotech firms. He has led research programmes resulting in multiple novel drug candidates and held senior leadership roles managing strategy, operations, and business development. Dr Pendri has guided executive teams, overseen global partnerships, and managed R&D and manufacturing operations across sites. He has authored more than 35 scientific publications and holds over 15 U.S. patents. Previously, he worked at Bristol-Myers Squibb. He holds a Ph.D. from the National Chemical Laboratory and completed postdoctoral work at UT Southwestern Medical Centre, USA.